Qiagen (NYSE:QGEN) will be posting its quarterly earnings results after the market closes on Monday, May 6th. Analysts expect Qiagen to post earnings of $0.26 per share for the quarter.
Qiagen (NYSE:QGEN) last posted its quarterly earnings results on Monday, February 4th. The company reported $0.40 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.40. Qiagen had a net margin of 12.68% and a return on equity of 12.15%. The firm had revenue of $403.20 million during the quarter, compared to analyst estimates of $409.32 million. During the same quarter in the prior year, the business posted $0.43 earnings per share. The company’s quarterly revenue was up 1.6% compared to the same quarter last year. On average, analysts expect Qiagen to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.
NYSE:QGEN opened at $38.96 on Friday. Qiagen has a 12-month low of $32.33 and a 12-month high of $41.55. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.22 and a quick ratio of 2.05. The stock has a market capitalization of $8.79 billion, a P/E ratio of 29.07, a price-to-earnings-growth ratio of 2.18 and a beta of 0.88.
WARNING: This article was originally published by Baseball Daily News and is owned by of Baseball Daily News. If you are reading this article on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.baseballdailydigest.com/news/2019/05/05/qiagen-qgen-to-release-earnings-on-monday.html.
QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide. The company offers sample technologies for plasmid deoxyribonucleic acid (DNA) purification, ribonucleic acid purification and stabilization, genomic and viral nucleic acid purification, DNA cleanup after polymerase chain reaction (PCR) and sequencing, target enrichment, and library preparation for sequencing applications; and assay technology solutions.
Featured Article: Understanding Market Liquidity
Receive News & Ratings for Qiagen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Qiagen and related companies with MarketBeat.com's FREE daily email newsletter.